Petmed Express Inc  

(Public, NASDAQ:PETS)   Watch this stock  
Find more results for PETS
-0.23 (-1.36%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.71 - 16.99
52 week 12.07 - 17.00
Open 16.99
Vol / Avg. 215,898.00/201,614.00
Mkt cap 339.20M
P/E 19.77
Div/yield 0.17/4.06
EPS 0.85
Shares 20.26M
Beta 1.11
Inst. own 70%
May 4, 2015
Q4 2014 Petmed Express Inc Earnings Release (Estimated) - 8:00AM EDT - Add to calendar
Jan 20, 2015
Q3 2014 Petmed Express Inc Earnings Call
Jan 20, 2015
Q3 2014 Petmed Express Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 9.73% 7.70%
Operating margin 15.55% 12.09%
EBITD margin - 12.46%
Return on average assets 24.16% 23.72%
Return on average equity 26.47% 26.78%
Employees 190 -
CDP Score - -


1441 SW 29 AVENUE
United States - Map
+1-954-9794788 (Phone)
+1-800-6008285 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company�s product line contains approximately 3000 stock keeping units (SKUS) of the pet medications, health products and supplies. These products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). The Non-Prescription Medications include flea and tick control products, bone and joint care products, vitamins and treats. The Prescription Medications (Rx) include heartworm preventatives, arthritis, thyroid and pain medications.

Officers and directors

Robert C. Schweitzer Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Menderes Akdag President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bruce S. Rosenbloom Chief Financial Officer, Treasurer
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank J. Formica Independent Director
Age: 69
Bio & Compensation  - Reuters
Gian M. Fulgoni Independent Director
Age: 67
Bio & Compensation  - Reuters
Ronald J. Korn Independent Director
Age: 73
Bio & Compensation  - Reuters